XML 18 R6.htm IDEA: XBRL DOCUMENT v3.21.2
CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY AND SERIES A CONVERTIBLE PREFERRED STOCK - USD ($)
Common Stock
Cumulative effect of adopting ASU 2020-06, adjusted balance
Common Stock
Additional Paid-in Capital
Cumulative effect of adopting ASU 2020-06, adjusted balance
Additional Paid-in Capital
Retained Earnings
Cumulative effect of adopting ASU 2020-06
Retained Earnings
Cumulative effect of adopting ASU 2020-06, adjusted balance
Retained Earnings
Treasury Stock
Cumulative effect of adopting ASU 2020-06, adjusted balance
Treasury Stock
Accumulated Other Comprehensive Loss
Cumulative effect of adopting ASU 2020-06, adjusted balance
Accumulated Other Comprehensive Loss
Cumulative effect of adopting ASU 2020-06
Series A Convertible Preferred stock
Cumulative effect of adopting ASU 2020-06
Cumulative effect of adopting ASU 2020-06, adjusted balance
Series A Convertible Preferred stock
Cumulative effect of adopting ASU 2020-06, adjusted balance
Series A Convertible Preferred stock
Total
Increase (Decrease) in Stockholders' Equity                                  
Cumulative effect of adopting ASU 2020-06   $ 977,000   $ 855,989,000     $ 1,408,333,000   $ (1,693,122,000)   $ (435,000)           $ 571,742,000
Balance (as adjusted) (in shares)   97,685                              
Beginning balance at Dec. 31, 2019   $ 977,000   855,989,000     1,408,333,000   (1,693,122,000)   (435,000)           571,742,000
Beginning balance (in shares) at Dec. 31, 2019   97,685                              
Increase (Decrease) in Stockholders' Equity                                  
Net income/(loss)   $ 0   0     (136,163,000)   0   0         $ 0 (136,163,000)
Foreign currency translation adjustment                     (936,000)           (936,000)
Change in derivative, net of tax                     (2,370,000)           (2,370,000)
Cash dividends declared common stock             (16,376,000)                   (16,376,000)
Stock-based compensation   $ 6,000   5,541,000                         5,547,000
Stock-based compensation (in shares)   566                              
Common stock issued under stock-based compensation plans   $ 2,000   111,000                         113,000
Common stock issued under stock-based compensation plans (in shares)   203                              
Treasury stock purchases                 (2,586,000)               (2,586,000)
Ending balance at Mar. 31, 2020   $ 985,000   861,641,000     1,255,794,000   (1,695,708,000)   (3,741,000)           418,971,000
Ending balance (in shares) at Mar. 31, 2020   98,454                              
Beginning balance at Dec. 31, 2019   $ 977,000   855,989,000     1,408,333,000   (1,693,122,000)   (435,000)           571,742,000
Beginning balance (in shares) at Dec. 31, 2019   97,685                              
Increase (Decrease) in Stockholders' Equity                                  
Net income/(loss)                                 (192,702,000)
Foreign currency translation adjustment                                 (532,000)
Change in derivative, net of tax                                 (3,837,000)
Preferred stock direct costs.                                 (10,257,000)
Ending balance at Jun. 30, 2020   $ 985,000   866,803,000     1,184,919,000   (1,695,974,000)   (4,804,000)         $ 204,079,000 351,929,000
Ending balance (in shares) at Jun. 30, 2020   98,465                           204  
Increase (Decrease) in Stockholders' Equity                                  
Cumulative effect of adopting ASU 2020-06   $ 985,000   861,641,000     1,255,794,000   (1,695,708,000)   (3,741,000)           418,971,000
Balance (as adjusted) (in shares)   98,454                              
Beginning balance at Mar. 31, 2020   $ 985,000   861,641,000     1,255,794,000   (1,695,708,000)   (3,741,000)           418,971,000
Beginning balance (in shares) at Mar. 31, 2020   98,454                              
Increase (Decrease) in Stockholders' Equity                                  
Net income/(loss)             (56,539,000)                   (56,539,000)
Foreign currency translation adjustment                     404,000           404,000
Change in derivative, net of tax                     (1,467,000)           (1,467,000)
Stock-based compensation       5,162,000                         5,162,000
Stock-based compensation (in shares)   (24)                              
Common stock issued under stock-based compensation plans (in shares)   35                              
Treasury stock purchases                 (266,000)               (266,000)
Series A preferred stock issuance                               $ 189,743,000  
Series A preferred stock issuance (in shares)                               200  
Preferred stock direct costs.             (10,257,000)                 $ 10,257,000 (10,257,000)
Paid-in-kind preferred stock dividend beneficial conversion feature             (4,079,000)                 $ 4,079,000 (4,079,000)
Paid-in-kind preferred stock dividend, including beneficial conversion feature (in shares)                               4  
Ending balance at Jun. 30, 2020   $ 985,000   866,803,000     1,184,919,000   (1,695,974,000)   (4,804,000)         $ 204,079,000 351,929,000
Ending balance (in shares) at Jun. 30, 2020   98,465                           204  
Increase (Decrease) in Stockholders' Equity                                  
Cumulative effect of adopting ASU 2020-06   $ 985,000   866,803,000     1,184,919,000   (1,695,974,000)   (4,804,000)         $ 204,079,000 351,929,000
Balance (as adjusted) (in shares)   98,465                           204  
Cumulative effect of adopting ASU 2020-06 $ 986,000 $ 986,000 $ 878,148,000 878,148,000 $ 4,763,000 $ 1,114,850,000 1,110,087,000 $ (1,696,743,000) (1,696,743,000) $ (3,785,000) (3,785,000) $ (4,763,000) $ 4,763,000 $ 213,485,000 $ 293,456,000 $ 218,248,000 288,693,000
Balance (as adjusted) (in shares) 98,645 98,645                       200   200  
Beginning balance at Dec. 29, 2020 $ 986,000 $ 986,000 878,148,000 878,148,000 4,763,000 1,114,850,000 1,110,087,000 (1,696,743,000) (1,696,743,000) (3,785,000) (3,785,000) (4,763,000) 4,763,000 $ 213,485,000 293,456,000 $ 218,248,000 288,693,000
Beginning balance (in shares) at Dec. 29, 2020 98,645 98,645                       200   200  
Increase (Decrease) in Stockholders' Equity                                  
Net income/(loss)             3,868,000                   3,868,000
Foreign currency translation adjustment                     174,000           174,000
Change in derivative, net of tax                     1,738,000           1,738,000
Cash dividends declared common stock             399,000                   399,000
Stock-based compensation   $ 3,000   5,480,000                         5,483,000
Stock-based compensation (in shares)   293                              
Common stock issued under stock-based compensation plans   $ 6,000   20,417,000                         20,423,000
Common stock issued under stock-based compensation plans (in shares)   570                              
Treasury stock purchases                 (3,957,000)               (3,957,000)
Cash dividend declared Series A preferred stock, $25.35 per share             (5,070,000)                   (5,070,000)
Ending balance at Mar. 30, 2021   $ 995,000   904,045,000     1,114,047,000   (1,700,700,000)   (1,873,000)         $ 213,485,000 316,514,000
Ending balance (in shares) at Mar. 30, 2021   99,508                           200  
Beginning balance at Dec. 29, 2020 $ 986,000 $ 986,000 $ 878,148,000 878,148,000 $ 4,763,000 $ 1,114,850,000 1,110,087,000 $ (1,696,743,000) (1,696,743,000) $ (3,785,000) (3,785,000) $ (4,763,000) $ 4,763,000 $ 213,485,000 $ 293,456,000 $ 218,248,000 288,693,000
Beginning balance (in shares) at Dec. 29, 2020 98,645 98,645                       200   200  
Increase (Decrease) in Stockholders' Equity                                  
Net income/(loss)                                 37,583,000
Foreign currency translation adjustment                                 393,000
Change in derivative, net of tax                                 3,464,000
Ending balance at Jun. 29, 2021   $ 1,052,000   850,601,000     1,134,186,000   (1,701,303,000)   72,000           284,608,000
Ending balance (in shares) at Jun. 29, 2021   105,196                              
Increase (Decrease) in Stockholders' Equity                                  
Cumulative effect of adopting ASU 2020-06   $ 995,000   904,045,000     1,114,047,000   (1,700,700,000)   (1,873,000)         $ 213,485,000 316,514,000
Balance (as adjusted) (in shares)   99,508                           200  
Beginning balance at Mar. 30, 2021   $ 995,000   904,045,000     1,114,047,000   (1,700,700,000)   (1,873,000)         $ 213,485,000 316,514,000
Beginning balance (in shares) at Mar. 30, 2021   99,508                           200  
Increase (Decrease) in Stockholders' Equity                                  
Net income/(loss)             33,715,000                   33,715,000
Foreign currency translation adjustment                     219,000           219,000
Change in derivative, net of tax                     1,726,000           1,726,000
Cash dividends declared common stock             15,000                   15,000
Stock-based compensation   $ 1,000   5,540,000                         5,541,000
Stock-based compensation (in shares)   44                              
Common stock issued under stock-based compensation plans   $ 1,000   4,361,000                         4,362,000
Common stock issued under stock-based compensation plans (in shares)   118                              
Common stock issuance   $ 31,000   167,019,000                         167,050,000
Common stock issuance (in shares)   3,125                              
Treasury stock purchases                 (603,000)               (603,000)
Series A preferred stock cash-settled conversion       (283,637,000)                       $ (160,114,000) (283,637,000)
Series A preferred stock cash-settled conversion (in shares)                               (150)  
Series A preferred stock conversion to common stock   $ 24,000   53,273,000                       $ (53,371,000) 53,297,000
Series A preferred stock conversion to common stock (in shares)   2,401                           (50)  
Deemed dividends on Series A preferred stock             (13,591,000)                   (13,591,000)
Preferred stock direct costs.                                 0
Ending balance at Jun. 29, 2021   $ 1,052,000   850,601,000     1,134,186,000   (1,701,303,000)   72,000           284,608,000
Ending balance (in shares) at Jun. 29, 2021   105,196                              
Increase (Decrease) in Stockholders' Equity                                  
Cumulative effect of adopting ASU 2020-06   $ 1,052,000   $ 850,601,000     $ 1,134,186,000   $ (1,701,303,000)   $ 72,000           $ 284,608,000
Balance (as adjusted) (in shares)   105,196